This is not an official government website.
© 2026 PLEJ LC. All rights reserved.
Congressional Daily Record
This section captures a floor statement or debate entry. It mentions committees such as Committee on Ways and Means.
Issued
April 20, 2026
house side of the record
People
0
No members linked from this section
Legislation
0
No linked legislation in this section
Committees
1
Committees connected to this section
Senate Holds
0
No hold activity linked here
Source Document
Connected Data
Committees
Source Control
Reader mode is for comprehension. The linked government PDF is the official published source.
Download official House Record PDFReturn to issue contextINTO THE UNITED STATES—MESSAGE FROM THE PRESIDENT OF THE UNITED STATES
(H. DOC. NO. 119-150)
from the President of the United States; which was read and, together with the accompanying papers, referred to the Committee on Ways and Means and ordered to be printed:
To the Congress of the United States:
Trade Expansion Act of 1962, as amended (19 U.S.C. 1862(c)(2)) (section 232), I am submitting to the Congress this written statement of the reasons why I have decided to take action to adjust imports of pharmaceuticals and pharmaceutical ingredients so that such imports will not threaten to impair the national security of the United States.
accordance with section 232, transmitted to me a report on his investigation into the effects of imports of pharmaceuticals and pharmaceutical ingredients on the national security of the United States. Based on the facts considered in that investigation, the Secretary found and advised me of his opinion that pharmaceuticals and associated active pharmaceutical ingredients, including key starting materials, are being imported into the United States in such quantities and under such circumstances as to threaten to impair the national security of the United States.
Pharmaceuticals and Pharmaceutical Ingredients Into The United States) (Proclamation), after considering the Secretary's report, the factors in section 232(d) (19 U.S.C. 1862(d)), and other relevant factors and information, among other things, I concurred with the Secretary's finding that pharmaceuticals and associated pharmaceutical ingredients are being imported into the United States in such quantities and under such circumstances as to threaten to impair the national security of the United States. In my judgment, and in light of the Secretary's report, the factors in section 232(d) (19 U.S.C. 1862(d)), and other relevant factors and information, I determined that it is necessary and appropriate to adopt a plan of action to adjust such imports of pharmaceuticals and associated pharmaceutical ingredients so that such imports will not threaten to impair the national security of the United States. In particular, I determined that it is necessary and appropriate for the Secretary and the Secretary of Health and Human Services, and any senior official they deem appropriate, to pursue or continue pursuing negotiations of agreements to address the threatened impairment of the national security with respect to imported pharmaceuticals and pharmaceutical ingredients. In the Proclamation, I noted that depending on the status or outcome of those negotiations, I may take other measures to adjust the imports of pharmaceuticals and pharmaceutical ingredients to address the threat to the national security found in the Proclamation. I also determined that it is necessary and appropriate to impose an immediate ad valorem duty rate on the import of certain patented pharmaceuticals and associated pharmaceutical ingredients to address the national security threat found in the Proclamation.
I am enclosing a copy of the Proclamation that I have issued. The Proclamation further explains the circumstances underlying the threat to impair the national security of the United States posed by imports of pharmaceuticals and pharmaceutical ingredients and the actions taken in the Proclamation to eliminate that threat.